He & She MD review

What the figure does not cover

Fees, terms and cancellation at He & She MD

Prepay

The injectable semaglutide annual plan bills $1,188 up front at $99 a month, and the tirzepatide annual plan bills $1,908, read August 2026. The site does not publish what happens to a paid term if the plan is canceled part-way through it.

Pricing transparency

How He & She MD publishes its prices

The banner reads 'Injectable Semaglutide $199/month from just $99/month', and the $99 is the annual plan, billed $1,188 up front. Injectable tirzepatide runs on the same shape at $159 a month, billed $1,908 for the year. The oral line is the one where the advertised figure changes underneath the buyer. GLP-1 Platinum oral is $199 a month for six months, then renews at $1,434 per six months, which is $239 a month. Six months at that renewal rate is $1,434, and the renewal is footnoted rather than printed on the program card. Every figure here was read in August 2026.

At a glance

Category

compounded GLP-1 sellers

Molecule

Semaglutide · Tirzepatide

Form

Injection · Oral

States

50

From

$99/mo · injection

From

$239/mo · oral

Prescription

Required

Compounded

Yes — not FDA-approved

Availability

50 states

The seller

What He & She MD is

He & She MD sells compounded semaglutide and compounded tirzepatide, by injection and as an oral tablet, with coverage stated across 50 states. Its plans are structured around terms paid up front rather than around a rolling monthly charge. The figures on the homepage are term rates rather than what a month costs on its own. The oral product sits outside the main term ladder and is priced from the program cards instead.

How it works

The term a buyer agrees to is what sets both the rate and the size of the first charge, and those two things pull in opposite directions. Committing to a year brings the injectable rate to $99 a month but requires $1,188 at the outset, and the tirzepatide equivalent requires $1,908. On the oral line the mechanism is different again. The rate is introductory for six months and then renews higher, so the cost of staying rises at a point the buyer has already passed. What happens to money already paid if a plan is stopped part-way is not something the site sets out.

Branded or compounded

All four lines are compounded preparations, so none is FDA-approved and none is reviewed by the FDA for safety or quality before dispensing. The oral tablets are compounded rather than the approved branded oral product, which is a difference that does not show up in a price comparison unless someone points at it. Nothing on the program cards states a milligram dose beside the figures.

Where the money holds, and where it moves

Who this is worth it for

Buyers who can pay a year up front and want the lowest annual rate.

Who should price elsewhere

Anyone reading the oral $199 as a rate that stays put.

Priced against

Sellers to price beside He & She MD

• Maximus

  Buyers comparing a full year against a single month before committing

  See Maximus →
• EDEdessa

  Buyers weighing the oral against the injection at one seller

  See Edessa →
• HEHealthRX

  Buyers who will commit a year and want a flat dose rate

  See HealthRX →

More GLP-1 telehealth sellers priced end to end: Lttl · MEDVi · Midi Health · PCOS Sisters · Piper · ShedRx

Who priced this, and how

Every figure above is what He & She MD publishes on its own pages, read in the month stated beside it, with any charge a buyer cannot decline added back before anything ranks. The rules a price has to meet before it appears here are set out in the methodology. A partnership sets display order on the surfaces that say so and never moves a score — how this site makes money.

Before you commit to a price